Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5946
    +0.0009 (+0.15%)
     
  • NZD/EUR

    0.5548
    +0.0002 (+0.03%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.91
    +0.10 (+0.12%)
     
  • GOLD

    2,329.70
    -8.70 (-0.37%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,265.29
    +64.02 (+0.37%)
     
  • NIKKEI 225

    37,636.61
    -823.47 (-2.14%)
     
  • NZD/JPY

    92.5190
    +0.4040 (+0.44%)
     

Why Moderna Stock Jumped 10.7% Today

Why Moderna Stock Jumped 10.7% Today

Shares of Moderna (NASDAQ: MRNA) rose more than 10% on Friday after the biotechnology company announced the commencement of its Phase 2 study for its novel coronavirus vaccine. Moderna said the first participants in each age group of its Phase 2 study have received doses of its experimental COVID-19 vaccine, mRNA-1273. Moderna is seeking to enroll 600 healthy participants, including 300 people aged 18-55 and 300 people older than 55.